ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 99 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,200,000 | -36.7% | 1,799,420 | -17.0% | 0.01% | -8.3% |
| Q4 2019 | $8,215,000 | -29.0% | 2,167,416 | -4.1% | 0.01% | -36.8% |
| Q3 2019 | $11,563,000 | -74.2% | 2,260,678 | -68.8% | 0.02% | -24.0% |
| Q2 2019 | $44,865,000 | +140.7% | 7,236,474 | +176.0% | 0.02% | -21.9% |
| Q1 2019 | $18,640,000 | -19.4% | 2,621,700 | -3.2% | 0.03% | -28.9% |
| Q4 2018 | $23,128,000 | -35.3% | 2,708,217 | +51.7% | 0.04% | -22.4% |
| Q3 2018 | $35,738,000 | +5.6% | 1,785,118 | +36.2% | 0.06% | 0.0% |
| Q2 2018 | $33,846,000 | +21.6% | 1,310,310 | +12.5% | 0.06% | +13.7% |
| Q1 2018 | $27,841,000 | -7.8% | 1,164,898 | +30.7% | 0.05% | -3.8% |
| Q4 2017 | $30,195,000 | +89.9% | 890,962 | +18.6% | 0.05% | +82.8% |
| Q3 2017 | $15,899,000 | – | 751,028 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|